New radiation method aims to zap anal cancer with fewer treatment breaks
NCT ID NCT02701088
Summary
This study tests a more precise radiation technique (SIB-IMRT) combined with standard chemotherapy drugs (5-FU and Mitomycin-C) for people with locally advanced anal cancer. The goal is to see if this approach can maintain cancer control while reducing severe side effects that typically force treatment breaks. Researchers will measure how well the cancer responds, track side effects, and assess patients' quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED ANAL CANAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Antoine Lacassagne
Nice, France
-
Centre François Baclesse
Caen, 14076, France
-
Centre Léon Berard
Lyon, France
-
Centre Paul Strauss
Strasbourg, France
-
IUCT-Oncopole
Toulouse, France
-
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, 54519, France
-
Institut de Cancérologie de l'Ouest - Centre Paul Papin
Angers, France
-
Institut de cancérologie de l'Ouest
Saint-Herblain, 44805, France
Conditions
Explore the condition pages connected to this study.